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Abstract
Background: Atrial fibrillation (AF) is the most common supraventricular arrhythmia in
the clinical practice, being the subject of intensive research.
Methods: The present work introduces two different Wavelet Transform (WT)
applications to electrocardiogram (ECG) recordings of patients in AF. The first one
predicts spontaneous termination of paroxysmal AF (PAF), whereas the second one
deals with the prediction of electrical cardioversion (ECV) outcome in persistent AF
patients. In both cases, the central tendency measure (CTM) from the first differences
scatter plot was applied to the AF wavelet decomposition. In this way, the wavelet
coefficients vector CTM associated to the AF frequency scale was used to assess how
atrial fibrillatory (f ) waves variability can be related to AF events.
Results: Structural changes into the f waves can be assessed by combining WT and
CTM to reflect atrial activity organization variation. This fact can be used to predict
organization-related events in AF. To this respect, results in the prediction of PAF
termination regarding sensitivity, specificity and accuracy were 100%, 91.67% and 96%,
respectively. On the other hand, for ECV outcome prediction, 82.93% sensitivity, 90.91%
specificity and 85.71% accuracy were obtained. Hence, CTM has reached the highest
diagnostic ability as a single predictor published to date.
Conclusions: Results suggest that CTM can be considered as a promising tool to
characterize non-invasive AF signals. In this sense, therapeutic interventions for the
treatment of paroxysmal and persistent AF patients could be improved, thus, avoiding
useless procedures and minimizing risks.
Keywords: Atrial Fibrillation, Central Tendency Measure, Electrical Cardioversion,
Electrocardiogram, Wavelet Transform
Introduction
TheWavelet Transform (WT) has emerged over recent years as one of the most favoured
tool by researches for analyzing problematic signals across a wide variety of areas in
science, engineering and medicine [1]. It is especially valuable because of its ability to elu-
cidate simultaneously local, spectral and temporal information from a signal in a more
flexible way than the short time Fourier Transform (STFT) by employing a window of
variable width. This flexible temporal-spectral aspect of the WT allows a local scale-
dependent analysis of individual signal features. In this way, both short duration with
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high frequency details and long duration with low frequency information can be captured
simultaneously. Hence, the method is particularly useful for the analysis of transients,
aperiodicities and other non-stationary signal features where subtle changes in signal
morphology may be highlighted over the scales of interest. Another key advantage of
wavelet techniques is the variety of wavelet functions available, thus allowing the most
appropriate to be chosen for the signal under investigation. These special features of the
WT have been applied to a wide variety of biomedical signals including electromyogra-
phy, electroencephalography, clinical sounds, respiratory patterns, blood pressure trends,
DNA sequences and electrocardiography [2,3]. Moreover, WT has also been successfully
employed to solve several problems dealing with electrocardiogram (ECG) signals, such
as feature extraction and discrimination between normal and abnormal beats, detection
of ventricular late potentials, evaluation of instantaneous changes in heart rate variability,
screening of patients with congestive heart failure, etc [4,5]. The present work introduces
two different WT applications to ECG signals of patients in atrial fibrillation (AF) that
will be next presented.
From an epidemiological point of view, AF is the most common cardiac arrhythmia,
affecting almost 5% of the population older than 69 years of age and 8% of the population
older than 80 years [6,7]. In this arrhythmia, there exist three main stages in which AF can
be placed depending on its usual evolution [8]. Paroxysmal atrial fibrillation (PAF) use to
be the first one. In this stage, the arrhythmia terminates spontaneously without the need
of medical intervention. The next stage is persistent AF, which requires pharmacological
or electrical cardioversion to allow its termination. Finally, the last stage is permanent AF,
in which the termination is impossible or is not recommended [6]. This supraventricu-
lar arrhythmia is characterized by uncoordinated atrial activation and occurs when the
electrical impulses in the atria degenerate from their usual organized pattern into a rapid
chaotic pattern [6]. Thus, AF is associated with multiple meandering activation waves
propagating randomly throughout the atria [9]. The fractionation of the wavefronts, as
they propagate, results in self-perpetuating independent wavelets, called reentries. On
the ECG, AF is described by the replacement of consistent P waves by rapid oscillations or
fibrillatory (f ) waves that vary in size, shape, and timing, associated with an irregular ven-
tricular response. Consequently, when AF occurs, a notably disorganized atrial activity
(AA) can be observed on the ECG [10].
The associated risks of AF are quite serious because this arrhythmia predisposes to
thrombus formation within the atria that can cause stroke or any other thromboembolic
events [6]. Since about 18% of PAF patients degenerate into persistent AF in less than
4 years [11], the early prediction of AF maintenance is crucial. Thus, appropriate inter-
ventions may terminate the arrhythmia and prevent AF perpetuation. In contrast, the
prediction of spontaneous PAF termination could avoid unnecessary therapy, reduce the
associated clinical costs and improve the patient’s quality of life. In this sense, one of
the WT applications that will be next introduced tries to predict the spontaneous PAF
termination.
On the other hand, electrical cardioversion (ECV) is one common therapy in the treat-
ment of persistent AF patients. In contrast to pharmacological cardioversion, ECV is the
most effective alternative to revert persistent AF back to normal sinus rhythm (NSR),
especially if the arrhythmia has been present for more than 24 hours [12]. Although the
ECV success rate is high, AF recurrence is common, especially during the first 2 weeks
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following the procedure [13]. Moreover, ECV has also the potential of causing severe col-
lateral effects, such as post-shock bradycardia, malignant ventricular arrhythmias, arterial
thromboembolism and complications related to anesthesia [12]. Hence, it would be clin-
ically very useful to predict NSR maintenance after ECV, before it is attempted. In this
way, the risks of cardioversion could be avoided for those patients with high risk of
short-term recurrence and, for the health care provider, clinical costs could be optimized
because unproductive treatment time and bed usage could be reduced. As a consequence,
other very useful application of the WT should be the prediction of ECV outcome in
persistent AF.
For the two aforementioned applications of the WT, i.e., the prediction of spontaneous
PAF termination and the prediction of ECV outcome in persistent AF, wavelet analysis
was combined with a non-linear approach, using continuous chaotic modelling that sum-
marizes the degree of variability in a signal, such as the central tendency measure (CTM)
[14]. More precisely, the CTM from the first differences scatter plot of the wavelet coeffi-
cients vector associated to the scale containing the typical AF frequency range, was used
to evaluate atrial activity f waves organization time course. To this respect, structural
changes into surface f waves reflect the intraatrial activity organization variation [15]. The
analysis of this variation is crucial, because several works have demonstrated a decrease
in the number of reentries prior to AF termination. Hence, this decrease will provoke an
organization variation in the f waves and the atrial activity (AA) will slightly evolve to
a more organized pattern before AF termination [16]. Moreover, in the context of ECV,
some works have also suggested that NSR maintenance would be more likely in patients
who present a highly organized AA, because themore disorganized the AA, the higher the
number of propagating wavelets [17] and the larger the atrial volume that could support
reentries propagation after the shock [18].
The remaining paper is structured as follows. Section Materials describes the used
databases, whereas section Methods explains preprocessing applied to ECG recordings,
the proposed algorithm based onWT and CTM to predict AF behavior and the statistical
study that was carried out. Section Results summarizes the obtained results, which are
next discussed in section Discussion. Finally, section Conclusions presents the concluding
remarks that will lead the paper to its end.
Materials
In this work two databases were employed. First, a set of PAF recordings were analyzed
to predict spontaneous termination of AF and, secondly, a set of persistent AF recordings
were studied to predict ECV outcome. In the next sub-sections, additional details in this
respect can be found.
Paroxysmal AF database
Fifty Holter recordings of 30 seconds in length and two leads (II and V1) available in
Physionet [19] were analyzed. The database included 26 non-terminating PAF episodes
(group N), which were observed to continue in AF for, at least, one hour following the
end of the excerpt, and 24 PAF episodes terminating immediately after the end of the
extracted segment (group T). These signals were digitized at a sampling rate of 128 Hz
and 16-bit resolution. Nonetheless, they were upsampled to 1024 Hz in order to allow
better alignment for QRST complex subtraction, such as Bollmann et al. suggested [10].
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This processing step is necessary to extract the AA from the surface ECG, see sectionData
preprocessing.
Persistent AF database
Sixty-three patients (20men and 43women,mean age 73.4± 9.0 years) with persistent AF
lasting more than 30 days, undergoing ECV were followed during four weeks. A standard
12-lead ECG was acquired for each patient during the whole procedure and a segment of
30 seconds in length preceding the cardioversion was extracted from each recording for
the analysis. All signals were digitized at a sampling rate of 1024 Hz and 16-bit resolution.
After the ECV, 22 patients (34.93%) maintained NSR during the first month. On the
contrary, in 31 patients (49.20%), NSR duration was below 1 month and the remaining 10
(15.78%) relapsed to AF immediately after ECV. These 41 patients constituted the group
of AF recurrence. All patients were in drug treatment with amiodarone. The median
arrhythmia duration was 10.58 months (range 1–47.22) and echocardiography demon-
strated a mean left atrium diameter (LAD) of 45.82 ± 6.93 mm. 20.63% of the patients
presented underlying heart disease. No statistically significant differences were found in
the aforementioned clinical parameters between the patients who maintained NSR and
relapsed to AF.
Methods
Data preprocessing
In both databases, lead V1 was chosen for the analysis because previous works have
shown that AA is dominant in this lead [20]. This signal was preprocessed using for-
ward/backward highpass filtering with 0.5 Hz cut-off frequency to remove baseline
wander, next, lowpass filtering with 70 Hz cut-off frequency was applied to reduce high
frequency noise and, finally, notch filtering at 50 Hz was applied to remove powerline
interference [21]. On the other hand, reliable analysis of the AA from surface ECG record-
ings requires that ventricular activity has first been cancelled [10]. Although a variety of
different techniques exist for this purpose, an adaptive singular value QRST cancellation
template was applied [22].
Wavelet Transform
From a mathematical perspective, the wavelet is a smooth and quickly vanishing oscillat-
ing function with good localization in both time and frequency. A wavelet family a,b(t)
is the set of elementary functions generated by dilations and translations of a unique
admissiblemother wavelet (t) [23], i.e.
a,b(t) = |a|− 12 
( t − b
a
)
, (1)
where a, b ∈ , a = 0 are the scale and translation parameters, respectively, and t is the
time. As a increases, the wavelet becomes narrower. Thus, one have a unique analytic
pattern and its replications at different scales and with variable time localization.
The Discrete Wavelet Transform (DWT) is the sampled version of the Continuous
Wavelet Transform (CWT) in a dyadic grid employing orthonormal wavelet basis func-
tions [23]. Hence, the parameters a and b are sampled using a logarithmic discretization
of the a scale (a = 2m) and this, in turn, is linked to the steps size taken between the b
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locations. To link b to a, each location b, which is proportional to the a scale, is moved in
discrete steps (b = n · 2m). Thus, the discretized mother wavelet is
m,n(k) = 2−m2 (2−mk − n), (2)
being m and n the new scale and translation discrete parameters, respectively, and k the
discrete time instant. Hence, the wavelet decomposition of the AA signal, xAA(k), can be
defined as its correlation with the chosen wavelet family m,n(k) for eachm and n, i.e.
Cm(n) =
∑
k
xAA(k) · m,n(k). (3)
The decomposition results in wavelet coefficients C, which depend on scale and posi-
tion. In fact, a vector of wavelet coefficients Cm is obtained for each analyzed discrete
scale m. The information stored in the wavelet coefficients vectors is not repeated
elsewhere and allows the complete regeneration of the original signal without redun-
dancy, because the used discretization of the mother wavelet employs orthonormal basis
functions [23].
Central Tendency Measure
Chaotic equations are sometimes used to generate graphs. Thus, the graph x(n + 2) −
x(n + 1) versus x(n + 1) − x(n) produces a scatter plot of first differences of the data,
x(n) being the value of a time series at time n. This plot, centered around the origin,
gives a graphical representation of the variability degree in the time series and is useful in
modeling biological systems, such as hemodynamics and heart rate variability [14]. With
this approach, rather than defining a time series as chaotic or not chaotic, the degree of
variability or chaos is evaluated.
The CTM is computed from a first differences scatter plot of the data selecting a circular
region of radius ρ around the origin, counting the number of points that fall within the
radius, and dividing by the total number of points. A low CTM value indicates a large
amount of dispersion and a high value indicates concentration near the centre. Given N
data points from a time series, N − 2 would be the total number of points in the scatter
plot. Then, the CTM can be computed as [14]
CTM =
∑N−2
i=1 δ(i)
N − 2 , (4)
where
δ(i) =
{
1, if
√(
x(i + 2) − x(i + 1))2 + (x(i + 1) − x(i))2 < ρ,
0, otherwise.
(5)
In the present work, f waves organization was estimated by computing the CTM from
the first differences scatter plot of the wavelet coefficients vector for the scale containing
the typical AF frequency range. For this purpose, a seven-level wavelet decomposition was
applied to the AA signal. The seventh discrete scale resulted in a good match to the AA
frequency band of interest [24], i.e. 4–8 Hz. In fact, the dominant atrial frequency (DAF),
i.e., the highest amplitude frequency, was within this range for all the analyzed patients.
Furthermore, previous works have proved that values for this frequency below 4 Hz or
above 8Hz are unusual [25].
A good matching between wavelet scale and AF frequency range is relevant to preserve
the essential behavior of the arrhythmia. In this respect, the DAF has provided to be a
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concomitant indicator of atrial refractroriness [26], thus revealing very clinically inter-
esting information about AF progression under different therapies [16]. Remark that for
sampling rates different from 1kHz, the seventh wavelet scale could not match properly
to the typical AF frequency range and, consequently, the proposed method performance
could be notably reduced. Thus, resampling up to 1kHz of new input ECG recordings has
to be considered as a previous step before their processing under the proposed method.
Optimal parameters selection
The proposed method performance depends on the chosen wavelet function and the
radius ρ selected for computation of CTM. However, there are no established rules for
the choice of their optimal values [2]. To this respect, a cautious and still exploratory
approach is to test different wavelet families and then to compare their efficiency in the
specific problem [27]. Unfortunately, on each electrocardiographic application where the
WT has been used, a different wavelet family was chosen [4]. In this study, several orthog-
onal wavelet families were tested, because only in an orthogonal basis any signal can be
uniquely decomposed and the decomposition can be inverted without loosing informa-
tion [23]. Thus, all the different functions from Haar, Daubechies, Coiflet, Biorthogonal,
Reverse Biorthogonal and Symlet wavelet families were tested.
On the other hand, an approach similar to the developed by Hornero et al [28] was
used to select the optimal ρ value. Thus, the CTM was computed for radius values of 0.1,
0.2, . . . , 10 times the standard deviation of the analyzed data, i.e., the wavelet coefficients
vector associated with the seventh discrete scale. Normalizing ρ in this way provides
translation and scale invariance, in the sense that CTM remains unchanged under uni-
form process magnification, reduction or constant shift to higher o lower values. To this
respect, note that the wavelet vector interesting information is carried by the coefficients
temporal variations, rather than its absolute amplitude variations. In fact, the amplitude
is only dependent on the similarity between the AA under study and the selected mother
wavelet. Hence, amplitude gives no useful information about f waves variability.
Statistical analysis
As the considered number of episodes for both analyzed databases was not notably large,
the proposed method was validated by a resubstitution approach, i.e., it was learned from
all the available data and then tested on the same set of data. The CTM value, for a spe-
cific ρ value and wavelet function, providing maximum discrimination between groups,
that is, the optimum threshold, was obtained by means of a receiver operating character-
istic (ROC) curve. The ROC curve is a graphical representation of the trade-offs between
sensitivity and specificity when discrimination threshold is varied. For PAF patients, sen-
sitivity (i.e. the true positive rate) was considered as the proportion of non-terminating
PAF episodes correctly discerned, whereas specificity (i.e. the true negative rate) repre-
sented the percentage of terminating episodes properly identified. Similarly, for the ECV
outcome analysis, sensitivity was the proportion of patients relapsing to AF appropri-
ately classified and specificity was the percentage of patients resulting in NSR after ECV
accurately predicted. The total number of PAF patients and ECVs precisely classified was
considered as the diagnostic accuracy corresponding to each prediction. The CTM value
providing the highest accuracy was selected as optimum threshold. The area under the
ROC curve (AROC) was also computed. AROC is a single number which represents a
Alcaraz and Joaquín Rieta BioMedical Engineering OnLine 2012, 11:46 Page 7 of 19
http://www.biomedical-engineering-online.com/content/11/1/46
summary of performance. For a perfect test the area is 1, while an AROC of 0.5 represents
a worthless test.
To verify representativeness of the used databases and generality of the results obtained
by the resubstitution approach, a leave-one-out cross-validation (LOOCV) scheme was
also used. In this procedure, the method was trained and tested a number of times equal
to the number of patients in the database. In each iteration, all the data, except for a
single observation, were used for training and the model was tested on that single obser-
vation. In addition, significant differences between terminating and non-terminating PAF
episodes and between patients who resulted in NSR and relapsed to AF were evaluated
making use of a Student’s t-test. All the groups had a normal and homoscedastic distri-
bution as the Shapiro–Wilk and Levene tests proved, respectively. A two-tailed value of
statistical significance p < 0.05 was considered statistically significant.
Results
Optimal parameters selection
For each studied wavelet function, CTM values from each patient group in the databases
were computed with a ρ equal to 3 times the standard deviation of the analyzed wavelet
coefficients vector. Preliminary experiments showed successful outcomes with this ρ that,
later, will be adaptedmore specifically. Differences between patient groups were evaluated
by means of Student’s t-test and sensitivity, specificity and accuracy of the classification
approach were computed making use of a ROC curve. In all the functions of the same
wavelet family, similar statistical significance values and the same sensitivity, specificity
and accuracy values were noticed for each analyzed AF scenario. Thus, only the func-
tion presenting the lowest p value is included in Tables 1 and 2 for each wavelet family.
As can also be appreciated in these tables, all the wavelet families reached the same dis-
criminant ability for each analyzed scenario.Moreover, the same patients were incorrectly
classified by all the families. Consequently, any wavelet family could be used indistinctly.
Nonetheless, both for PAF termination and ECV result predictions, the lowest statistical
significance value was noticed for biorthogonal family of order (4,4), such as in previous
works [29,30]. Thus, considering that only one wavelet function can be applied to the
proposed methodology, the aforementioned wavelet function was selected.
After optimal wavelet function selection, the proposed method dependence on the
radius ρ was investigated following the process described in section Optimal parameters
Table 1Mean and standard deviation of CTM values for non-terminating and terminating
AF groups, statistical significance (p value), sensitivity, specificity, accuracy and result
from the LOOCV approach for each studied wavelet family
Wavelet Family Group N Group T p value Sensitivity Specificity Accuracy LOOCV
(Order)
Haar 0.939±0.062 0.795±0.060 <0.001 92.31% 91.67% 92% 92%
Daubechies (5) 0.936±0.060 0.792±0.059 <0.001 92.31% 91.67% 92% 92%
Coiflet (3) 0.931±0.060 0.793±0.046 <0.001 92.31% 91.67% 92% 92%
Biorthogonal (4.4) 0.943±0.054 0.798±0.050 < 0.001 92.31% 91.67% 92% 92%
Reverse Biorthogonal 0.928±0.059 0.789±0.049 < 0.001 92.31% 91.67% 92% 92%
(4.4)
Symlets (5) 0.931±0.060 0.791±0.058 < 0.001 92.31% 91.67% 92% 92%
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Table 2Mean and standard deviation of CTM values for patients relapsing to AF andmaintaining NSR during the first month post-cardioversion, statistical
significance (p value), sensitivity, specificity, accuracy and result from the LOOCV approach for each studied wavelet family
Wavelet Family (Order) ECVs relapsing to AF ECVs maintaing NSR p value Sensitivity Specificity Accuracy LOOCV
Haar 0.698±0.047 0.819±0.071 < 0.001 80.48% 81.81% 80.95% 79.37%
Daubechies (5) 0.693±0.051 0.818±0.069 < 0.001 80.48% 81.81% 80.95% 79.37%
Coiflet (3) 0.688±0.052 0.810±0.066 < 0.001 80.48% 81.81% 80.95% 79.37%
Biorthogonal (4.4) 0.691±0.052 0.812±0.067 < 0.001 80.48% 81.81% 80.95% 79.37%
Reverse Biorthogonal (4.4) 0.690±0.053 0.813±0.067 < 0.001 80.48% 81.81% 80.95% 79.37%
Symlets (5) 0.691±0.052 0.808±0.065 < 0.001 80.48% 81.81% 80.95% 79.37%
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selection. For each tested ρ value, statistical differences between terminating and non-
terminating PAF episodes and between patients who relapsed to AF and maintained NSR
after ECV were evaluated by using Student’s t-test. In both cases, statistically significant
differences were found for ρ values between 2.8 and 5.6. Nonetheless, the lowest p value
was noticed for ρ = 3.3 and ρ = 4 in PAF termination and ECV outcome predictions,
respectively. Thereby, the CTM was computed with these ρ values in each analyzed AF
scenario.
Classification performance
For PAF termination prediction, CTM values computed with previously described opti-
mal parameters provided sensitivity, specificity and accuracy of 100% (26 out of 26),
91.67% (22 out of 24) and 96% (47 out of 50). In addition, 94% (46 out of 50) of
cross-validated grouped cases were correctly identified. The ROC curve provided 0.888
as optimum discrimination threshold between terminating and non-terminating PAF
episodes with an AROC of 0.974, see Figure 1(a). Additionally, Figure 1(b) shows that the
non-terminating PAF episodes presented higher CTM values (0.963 ± 0.036) than the
terminating ones (0.855± 0.040). As an example, Figure 2 shows a 10 second-length ECG
interval, its extracted AA signal, the wavelet coefficients vector corresponding with the
seventh discrete scale and its first differences scatter plot for a typical terminating PAF
episode and other non-terminating one. Faster temporal variations within the wavelet
coefficients vector and, hence, higher dispersion in scatter plot and lower CTM value can
be appreciated for the terminating AF episode.
Regarding ECV outcome prediction, the ROC curve provided 0.823 as optimum CTM
discrimination threshold, in which 82.93% (34 out of 41) sensitivity and 90.91% (20 out
of 22) specificity were obtained, see Figure 3(a). Hence, the ECV outcome in 54 out of 63
patients (85.71%) was correctly predicted, with 82.54% (52 out of 63) of cross-validated
grouped cases appropriately identified. An AROC of 0.940 was achieved. Moreover, the
patients relapsing to AF presented lower CTM values (0.761± 0.054) than those resulting
in NSR after one month (0.880 ± 0.050), such as Figure 3(b) shows. As for PAF termi-
nation prediction, Figure 4 presents typical ECG intervals, extracted AA signals, wavelet
coefficients and scatter plots for a patient who maintained NSR and other relapsing to AF
during the first month post-cardioversion of persistent AF. In this case, a higher variation
rate within the wavelet coefficients, associated with a lower CTM value, was observed for
patients who relapsed to AF.
Other interesting result from Figure 3(b) is that all the patients relapsing to AF imme-
diately after ECV were appropriately identified with a CTM threshold of 0.749. Indeed,
these patients presented CTM values (0.727 ± 0.021) lower than the remaining ones who
relapsing to AF during the first month post-cardioversion (0.771 s´ 0.057), the statistical
significance being lower than 0.001. Nonetheless, note that the false positive rate was
32.26% (10 out of 31).
Discussion
Comparison with previous works
Non-linear analysis metrics are a valuable tool in the assessment of physiological
time series because hidden information related to underlying mechanisms can be
obtained [31,32]. To this respect, it has become evident through a number of studies that
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Figure 1 Results for PAF prediction. (a) ROC curve constructed with the obtained CTM values for PAF
patients from the seventh discrete scale wavelet coefficients of the AA signal. Biorthogonal wavelet family of
order (4,4) and a ρ value of 3.3 times the standard deviation of analyzed data were used as parameters for
CTM computation. The CTM value providing the highest accuracy was selected as optimum threshold, which
has been marked with symbol •. (b) Classification into terminating and non-terminating PAF episodes.
the cardiac system is non-linear on its behavior [33]. Furthermore, regarding the employ-
ment of non-linear metrics, Sample Entropy (SampEn) has been successfully applied to
the surface ECG in AF. In this case, SampEn has been computed over the main atrial
wave (MAW). The MAW is the fundamental waveform associated to the AA signal and
has served as the starting point to estimate non-invasively AF organization. Through the
MAW-SampEn strategy, it has been possible to achieve a diagnostic ability of 90% in the
prediction of PAF termination [34] and approximately 80% in the prediction of ECV out-
come [35]. Similarly, f waves regularity has also been assessed through the application
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Figure 2 Representative plots for PAF prediction. Typical ECG interval together with its extracted AA
signal and the wavelet coefficient vector corresponding with the seventh discrete scale together with its
scatter plot of first differences for (a) a non-terminating and (b) other terminating PAF episode.
of SampEn to the wavelet domain of the AA signal. In this case, the wavelet-SampEn
approach reached a discriminant capability of 90 and 82% for PAF termination and ECV
outcome predictions, respectively [29,30]. Nonetheless, SampEn might be notably sensi-
tive to the presence of noise [34,36] and spikes [37]. Thus, given that QRST residua are
often present in the extracted AA [20,22] and the predictive ability of Wavelet-SampEn
could be improved, the analysis of alternative non-linear methods is desirable to develop
top performance single classificators of AF organization-related events.
In the present work the CTM from the first differences scatter plot of the wavelet coef-
ficients vector associated to the AF frequency scale has been analyzed. The presented
strategy reached the highest diagnostic ability as a single predictor published to date, i.e.,
96% and 86% for PAF termination and ECV outcome, respectively. Given that compar-
ison with previous works can be unfair for some cases because different datasets were
used, Tables 3 and 4 present the most recently proposed methods, together with relevant
information about their validation and performance, to predict PAF termination and ECV
outcome, respectively. As aforesaid, AF organization evaluation based on MAW-SampEn
or in Wavelet-SampEn provided interesting diagnostic accuracies in both analyzed AF
scenarios, but lower than the Wavelet-CTM strategy. In a similar way, the f waves ampli-
tude also showed an interesting ability in the prediction of ECV outcomewith an accuracy
near 80% [38] but, again, lower than this new introduced strategy.
Regarding the frequency domain, a variety of works analyzed the DAF of the AA sig-
nal, providing diagnostic abilities in PAF termination prediction between 86% and 90%,
depending on the used method for its computation [40,41]. Holmqvist et. al. [44] eval-
uated a parameter obtained from time-frequency analysis of the AA signals, such as
harmonic decay [24], but a low number of patients relapsing to AF after ECV were
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Figure 3 Results for ECV result prediction. (a) ROC curve constructed with the obtained CTM values for
persistent AF patients from the seventh discrete scale wavelet coefficients of the AA signal. Biorthogonal
wavelet family of order (4,4) and a ρ value of 4 times the standard deviation of analyzed data were used as
parameters for CTM computation. The CTM value providing the highest accuracy was selected as optimum
threshold, which has been marked with symbol •. (b) Classification into patients resulting in NSR and
relapsing to AF after 4 weeks following ECV.
correctly identified (47%). Finally, in [46], ventricular rhythm was analyzed using three-
dimensional RR intervals plots, quantifying clustering of RR intervals, however, only 50%
of patients who relapsed to AF during the first 4 weeks following ECV were correctly
discerned.
Nevertheless, single parameters combinations and advanced classification tools can be
found in the literature to predict AF behavior. Thus, regarding PAF termination predic-
tion, DAF has been combined with other parameters to improve its diagnostic accuracy.
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Figure 4 Representative plots for ECV result prediction. Typical ECG interval together with its extracted
AA signal and the wavelet coefficient vector corresponding with the seventh discrete scale together with its
scatter plot of first differences for (a) a patient who maintained NSR and (b) other relapsing to AF during the
first month post-cardioversion.
To this respect, Petrutiu et al [42] studied the AA peak frequency power evolution within
the last two seconds before spontaneous PAF termination, reaching thus an accuracy of
93.33%. The same classification result was reported by combining SampEn and WT [29].
In that work, SampEn was used to assess f waves regularity from the time and wavelet
domains of the AA signal, providing two different and independent classifications, which
were combined as a function of the DAF. A slightly higher result (accuracy of 96.67%) was
reached by Sun & Wang [39] making use of a multilayer perceptron neural network to
combine 11 features extracted from the ECG recurrence plot quantification. With regard
to ECV outcome prediction, Watson et al [43] examined a variety of wavelet transform-
based statistical markers, which obtained a sensitivity of 88% and specificity of 100%
by means of a non-parametric classification system. Zohar et al [45] developed a non-
deterministic model with several parameters as inputs for predicting NSR maintenance
after ECV, providing a diagnostic accuracy of 84%. As for PAF termination prediction, the
AA signal organization estimation both in time and wavelet domains through SampEn
provided an sensitivity of 95% and specificity of 93% [30]. However, it is worth noting that
in this study only patients undergoing the first attempt of ECV and, therefore, with AA
signals notably organized [47], were analyzed. Finally, recent works have reported that the
combination of f waves amplitude with the DAF [38] and SampEn [35] computed from
the MAW reached a discriminant ability of 86 and 90%, respectively.
Bearing this context in mind, it can be noticed that only complex combinations of single
predictors can improve the CTM classification result. Thereby, the proposed metric can
be considered as a promising single estimator of PAF termination and ECV outcome pre-
diction, with the additional advantage of a simpler implementation to work in real-time.
To this respect, DWT can be computed efficiently with a pyramid filter bank algorithm
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Table 3 Comparison between themost recent studies presented to predict PAF termination
Study Database Short description of methods Diagnostic
accuracy
This work Cinc/Challenge 2004 [19] CTM from the first differences scatter plot of
the wavelet coefficient vector associated to the
AF frequency scale of the AA
96%
Alcaraz & Rieta 2009 [34] Cinc/Challenge 2004 [19] Regularity analysis via SampEn from the MAW
of the AA signal
93%
Sun & Wang 2008 [39] Cinc/Challenge 2004 [19] Combination of features extracted from the
ECG recurrence plot quantification making use
of a multilayer perceptron neural network
96%
Alcaraz & Rieta 2008 [29] Cinc/Challenge 2004 [19] Regularity analysis via SampEn of time and
wavelet domains of the AA
93%
Alcaraz et al 2008 [40] Own Database with 50 episodes:
21 non-terminating and 29 termi-
nating
Analysis of time and frequency parameters
obtained from the AA
92%
Nilsson et al 2006 [41] Cinc/Challenge 2004 [19] Analysis of time and frequency parameters and
non-linear indices obtained from the AA
90%
Petrutiu et al 2004 [42] Cinc/Challenge 2004 [19] Experimental combination of AA peak power
evolution within the two last seconds of the
episode with the DAF
93%
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Table 4 Comparison between themost recent studies presented to predict ECV outcome
Study Database Short description of methods Diagnostic accuracy
This work Own database with 63 patients: 31 relapsed
to AF, 22 maintained NSR and 10 presented
unsuccessful ECV
CTM from the first differences scat-
ter plot of the wavelet coefficient
vector associated to the AF fre-
quency scale of the AA
86%
Alcaraz et al 2011 [35] Own database with 63 patients: 31 relapsed
to AF, 22 maintained NSR and 10 presented
unsuccessful ECV
Combination of f waves amplitude
and SampEn computed from the
MAW of the AA
90%
Alcaraz & Rieta 2009 [38] Own database with 63 patients: 31 relapsed
to AF, 22 maintained NSR and 10 presented
unsuccessful ECV
Discriminant model based on
time and frequency parameters
obtained from the AA
86%
Alcaraz & Rieta 2008 [30] Own database with 40 patients: 21 relapsed
to AF, 14 maintained NSR and 5 presented
unsuccessful ECV
Regularity analysis via SampEn of
time and wavelet domains of the
AA
94%
Watson et al 2007 [43] Own database with 30 patients: 17 relapsed
to AF and 13 maintained NSR
Non-parametric combination of
several wavelet transform-based
statistical markers
93%
Holmqvist et al 2006 [44] Own database with 54 patients: 30 relapsed
to AF and 24 maintained NSR
Assessment of the atrial harmonic
decay with time-frequency analysis
of the ECG
70%
Zohar et al 2005 [45] Own database with 44 patients: 21 relapsed
to AF and 23 maintained NSR
Non-deterministiscmodel based on
genetic programming
84%
Berg et al 2004 [46] Own database with 66 patients: 32 relapsed
to AF, 22 maintained NSR and 12 presented
unsuccessful ECV
Analysis of 3D RR intervals as a
quantifier of AF organization
52%
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[23], allowing thus its implementation in real-time [48,49]. In contrast, the classical algo-
rithm proposed in the literature for SampEn computation requires a high execution time,
which is not fast enough for online applications [50]. Although faster alternatives for Sam-
pEn computation have been recently proposed [50,51], their ability to be implemented in
real-time environments has not been proved yet. In addition, accuracy of these new algo-
rithms has not been validated by comparison with the classical SampEn definition. On the
other hand, it has to be remarked that the complex combination of multiple parameters
or the use of advanced classification techniques, such as in [39] or in [43], makes difficult
the clinical interpretation of the results. In this sense, possible clinical meaning of each
parameter is blurred within the classification approach.
Interpretation of results
Taking a specific wavelet decomposition scale, the coefficients vector contains the simi-
larity evolution through time between the analyzed signal and the scaled mother wavelet.
A low variability in this time series implies an invariable waveform, regardless of its con-
crete shape, along the studied time period. In contrast, high variability implies variable
waveforms that may, eventually, evolve to a more organized pattern. This fact justifies the
results obtained in the prediction of spontaneous PAF termination, where terminating
episodes presented wavelet vectors with higher variability than non-terminating ones, see
Figure 1. The AA evolution from disorganized f waves to organized P waves that takes
place in AF recordings prior to its termination may cause this behavior in the wavelet
coefficients vector [20].
Regarding ECV result analysis, the presence of more structured f waves in organized
AA signals [15,20] could justify the obtained results, which show that patients who
relapsed to AF presented wavelet coefficients vectors with higher variability than those
who remained in NSR, see Figure 3. In fact, patients relapsing to AF immediately after
ECV presented, in average, lower CTM values than the remaining ones. These findings,
suggestingmore organizedAA signals in effective cardioversions onemonth after the pro-
cedure, agree with observations obtained from previous works, such as: (i) the higher the
AA organization, the higher the success rate in AF cardioversion [17,52], (ii) the higher
the AA organization, the lower the energy required for successful cardioversion [18] and
(iii) PAF requires less energy for cardioversion than persistent AF [53]. These observa-
tions highlight the fact that, when a higher number of reentries are wandering throughout
the atrial tissue, a lower probability of successful ECV is obtained. One possible explana-
tion could be that a low degree of AA organization might result in an increased mass of
atrial myocardium that is not fully excitable [52].
Study limitations
The analysis was developed with a limited group of patients. Hence, a larger sample allow-
ing a more rigorous statistical study would be required to provide improved confidence
in the robustness of the developed approach. To this respect, wider databases containing
non-terminating and spontaneously terminating PAF episodes after different time epochs
(ten minutes, half an hour, an hour, ten hours, etc.) and patients who resulted in NSR and
relapsed to AF after 3, 6, and 12 months following ECV would be necessary. In addition,
the availability of longer PAF recordings would allow to address the interesting question
about the time in advance with which spontaneous PAF termination could be predicted.
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On the other hand, the persistent AF database only included suitable ECV patients fol-
lowing the standard clinical criteria; therefore, it is unknown how the proposed algorithm
will behave in patients with adverse clinical predictors, like atrial dilatation, etc., which, by
default, are excluded from ECV procedures. Finally, only lead V1 was analyzed rejecting
the possible information contained in the remaining leads. However, for this type of stud-
ies, lead V1 seems to be the most suitable lead because significant correlations between
the atrial frequency [54] and SampEn [15] obtained from this lead and those obtained
from atrial electrograms have been observed.
Conclusions
The present work has demonstrated that AF organization can be evaluated non-invasively
through the application of CTM to the wavelet coefficients vector containing the AF
frequency range. This non-linear index has proved to be the most predictive single esti-
mator of spontaneous PAF termination and ECV outcome published to date. Nonetheless,
although complex and advanced combinations of other parameters measured from the
ECG can improve its diagnostic ability, the proposed algorithm has interesting advan-
tages, including a clear clinical interpretation of the results and the possibility of real-time
operation. Hence, its use may lead towards the development of improved therapeutic
interventions for the treatment of paroxysmal and persistent AF, since useless procedures
could be avoided and the consequent risk for the AF patients could be minimized.
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